ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
18 hedge funds and large institutions have $1.72M invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
6% more funds holding
Funds holding: 17 → 18 (+1)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
52% less capital invested
Capital invested by funds: $3.61M → $1.72M (-$1.88M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$79.7K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.8K |
| 3 |
Citigroup
New York
|
+$1.02K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$942 |
| 5 |
Goldman Sachs
New York
|
+$335 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Platinum Management
New York
|
-$4.34M |
| 2 |
NPC
National Planning Corporation
El Segundo,
California
|
-$37K |
| 3 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$17K |
| 4 |
Renaissance Technologies
New York
|
-$13.6K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$9.64K |
ECTE Hedge Fund Activity: Q1 2015 in Review
18 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q1 2015, worth a combined $1.72M — down 52% from $3.61M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ECTE positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Brandes Investment Partners, opening a new position worth an estimated $79.7K. The largest seller was Platinum Management, cutting an estimated $4.34M.
- 18 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q1 2015, up from 17 in Q4 2014.
- Funds reported $1.72M of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q1 2015, down 52% quarter-over-quarter.
- 5 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q1 2015 and 3 closed out, a net change of +2 holders.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q1 2015 was Brandes Investment Partners, an estimated $79.7K added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q1 2015 was Platinum Management, an estimated $4.34M sold.
Based on aggregated 13F filings for Q1 2015.